Table 4.
Overall comparison of clinical and biological characteristics between the clusters.
| Cluster 1 | Cluster 2 | Cluster 3 | Cluster 4 | p-value global test | |
|---|---|---|---|---|---|
| Number | 20 | 19 | 20 | 15 | |
| Men, n (%) | 12 (60%) | 14 (74%) | 8 (40%) | 9 (60%) | 0.21091 |
| Age, (years) mean, sd | 70 (15) | 69 (14) | 72 (14) | 73 (14) | 0.62652 |
| CRP, (mg/L) mean (sd) (n=73) | 89.4 (84.89) | 82.1 (70.77) | 47.8 (44.08) | 63.7 (53.86) | 0.25982 |
| Severe COVID-193, n (%) | 14 (70%) | 9 (47.37%) | 9 (45%) | 11 (73.33%) | 0.19121 |
| ICU admission, n (%) | 6 (30%) | 5 (26.32%) | 4 (20%) | 8 (53.33%) | 0.1991 |
| Oxygen requirement, n (%) | 18 (90%) | 13 (68.42%) | 11 (55%) | 12 (80%) | 0.7741 |
| Mortality, dead, n (%) | 2 (10%) | 0 (0%) | 2 (10%) | 4 (26.67%) | 0.0484 |
| Corticoid requirement, n (%) | 10 (50%) | 4 (21.05%) | 2 (10%) | 7 (46.67%) | 0.01811 |
Reference values: CRP < 10 mg/L.
1Fisher exact test. 2 Kruskal-Wallis test. 3 Severe COVID-19 defined as: O2 > 2 L/min, ICU [intensive care unit] admission, LTE [limitation of the therapeutic effort], decease. 4 Post-hoc analysis with Fisher exact test.